Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
European Journal of Haematology|November 17, 2011
Lenalidomide in multiple myeloma: current experimental and clinical dataMauro Cives, Annalisa Milano, Franco Dammacco, et al.Oncotarget|July 16, 2016
NETs: organ-related epigenetic derangements and potential clinical applicationsMauro Cives, Valeria Simone, Francesca Maria Rizzo, et al.The Oncologist|January 18, 2014
New insights into the molecular pathogenesis of langerhans cell histiocytosisFrancesca M Rizzo, Mauro Cives, Valeria Simone, et al.International Journal of Molecular Sciences|April 30, 2020
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast CancerStella D'Oronzo, Erica Silvestris, Angelo Paradiso, et al.Critical Reviews in Oncology/Hematology|July 20, 2012
Novel lenalidomide-based combinations for treatment of multiple myelomaMauro Cives, Valeria Simone, Oronzo Brunetti, et al.Neuroendocrinology|July 3, 2020
Sensitivity and Specificity of the NETest: A Validation StudyTaymeyah Al-Toubah, Mauro Cives, Tiffany Valone, et al.Journal of the National Cancer Institute|May 10, 2018
Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine TumorsMauro Cives, Daniel A Anaya, Heloisa Soares, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|March 13, 2023
An update on Merkel cell carcinomaMaria Chiara Sergi, Eleonora Lauricella, Camillo Porta, et al.Current Treatment Options in Oncology|July 27, 2019
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine TumorsMauro Cives, Eleonora Pelle', Davide Quaresmini, et al.Journal of Neuroendocrinology|September 8, 2022
The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patientsMauro Cives, Jorge Hernando, Angela Lamarca, et al.Pageof 8